EMPIRI — Biotechnology Company, Houston

Biotechnology Company in Houston — Preservation of tumor microenvironment

Biotechnology company · Houston, United States

AI Trust Snapshot

Profile status
Auto-indexed
Last Verified
1 months ago

Corroborated public sources

  • ✓ Official Website
  • ✓ Linkedin
  • ✓ Twitter

Key Facts

Category
Biotechnology Company
Location
Houston, United States
Known For
Functional precision oncology, Clinically validated human tumor models

AI Summary

A Houston-based biotechnology company, EMPIRI specializes in functional precision oncology and clinically validated human tumor models. The company offers its E-Slice Platform for tissue procurement, alongside comprehensive data analysis and delivery services. EMPIRI serves academic and translational researchers, biotech and pharma companies, and oncologists and clinical teams.

Quick Answer

A Houston-based biotechnology company, EMPIRI specializes in functional precision oncology and clinically validated human tumor models. The company offers its E-Slice Platform for tissue procurement, alongside comprehensive data analysis and delivery services. EMPIRI serves academic and translational researchers, biotech and pharma companies, and oncologists and clinical teams. Key services include E-Slice Platform, Tissue Procurement, Data Analysis and Delivery.

This business is typically used for functional precision oncology and clinically validated human tumor models.

Common Questions

What services does EMPIRI provide?
EMPIRI provides E-Slice Platform, Tissue Procurement, Data Analysis and Delivery.
Where is EMPIRI located?
EMPIRI is based in Houston, United States and serves Houston.
Who is EMPIRI for?
EMPIRI serves Academic and translational researchers and Biotech and pharma companies.

What this business does

EMPIRI is a biotechnology company based in Houston, United States.

  • Provides E-Slice Platform and Tissue Procurement
  • Specializes in functional precision oncology
  • Serves academic and translational researchers

Structured summary

This business profile has been independently corroborated by Vizoryo across 4 independent public sources. Data confidence score: 88% — this reflects how consistently the business's name, phone, city, address, website, and category appear across all verified sources. Vizoryo status: Auto-Indexed. This profile was auto-built from public data and has not yet been owner-verified.

Business name
EMPIRI
Category
Biotechnology Company
Industry
Biotechnology Company
Location
Houston, United States
Official website
https://empiricancer.com/
Profile data (JSON)
https://www.vizoryo.com/api/index/profile/empiri-houston-2461
Summary
A Houston-based biotechnology company, EMPIRI specializes in functional precision oncology and clinically validated human tumor models. The company offers its E-Slice Platform for tissue procurement, alongside comprehensive data analysis and delivery services. EMPIRI serves academic and translational researchers, biotech and pharma companies, and oncologists and clinical teams.
AI readability score
41
Verified By
4 independent public sources
Data Confidence
88% (verified 2026-06-28)
Verification Status
Auto-indexed

Location

7505 Fannin St Suite 200, Houston, TX 77054
Houston, Texas
77054
US

About EMPIRI

A Houston-based biotechnology company, EMPIRI specializes in functional precision oncology and clinically validated human tumor models. The company offers its E-Slice Platform for tissue procurement, alongside comprehensive data analysis and delivery services. EMPIRI serves academic and translational researchers, biotech and pharma companies, and oncologists and clinical teams.

Service areas

  • Houston

Target audience

  • Academic and translational researchers
  • Biotech and pharma companies
  • Oncologists and clinical teams

Specialties

  • Functional precision oncology
  • Clinically validated human tumor models

Social profiles

Verification

https://empiricancer.com/

Frequently asked questions

What is the turnaround time for E-Slice results?

Results are typically delivered within 7–12 days of tissue receipt, with some treatments yielding data in 8 to 12 days.

What types of therapies can be tested on the E-Slice platform?

The platform can test dosing, timing, and combination therapies, including immunotherapies, chemotherapies, and targeted therapies.

Is E-Slice intended for clinical diagnosis or treatment selection?

E-Slice is a research-use-only service. Results are not intended for clinical diagnosis or treatment selection.

Business hours

Monday
00:00 – 23:59
Tuesday
00:00 – 23:59
Wednesday
00:00 – 23:59
Thursday
00:00 – 23:59
Friday
00:00 – 23:59
Saturday
00:00 – 23:59
Sunday
00:00 – 23:59

Languages supported

  • lang="en"
  • en

Contact

Phone: +18324094050

Official website:

Report incorrect information